Technical Analysis for SIBN - SI-BONE, Inc.

Grade Last Price % Change Price Change
F 14.57 2.10% 0.30
SIBN closed up 2.1 percent on Friday, April 26, 2024, on 64 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Apr 29
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 2.10%
New 52 Week Low Weakness 2.10%
Stochastic Reached Oversold Weakness 2.10%
BB Squeeze Ended Range Expansion 2.10%
Below Lower BB Weakness 2.10%

   Recent Intraday Alerts

Alert Time
Up 3% 2 days ago
60 Minute Opening Range Breakout 2 days ago
Rose Above Lower Bollinger Band 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

SI-BONE, Inc. Description

SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment. There are over 60 peer-reviewed publications supporting the safety, effectiveness, and biomechanical and economic benefits unique to the iFuse Implant. This body of evidence has enabled multiple government and private payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Dysfunction Prosthetics Implant Quality Of Life Minimally Invasive Procedure Surgical Treatment Pelvis Joint Dysfunction Medical Classification Sacroiliac Joint

Is SIBN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 29.51
52 Week Low 14.12
Average Volume 473,643
200-Day Moving Average 19.48
50-Day Moving Average 16.69
20-Day Moving Average 15.38
10-Day Moving Average 15.13
Average True Range 0.62
RSI (14) 37.11
ADX 18.16
+DI 16.65
-DI 26.28
Chandelier Exit (Long, 3 ATRs) 14.98
Chandelier Exit (Short, 3 ATRs) 15.98
Upper Bollinger Bands 16.28
Lower Bollinger Band 14.48
Percent B (%b) 0.05
BandWidth 11.68
MACD Line -0.49
MACD Signal Line -0.49
MACD Histogram -0.0028
Fundamentals Value
Market Cap 590.1 Million
Num Shares 40.5 Million
EPS -1.18
Price-to-Earnings (P/E) Ratio -12.35
Price-to-Sales 6.47
Price-to-Book 4.91
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.59
Resistance 3 (R3) 15.55 15.18 15.42
Resistance 2 (R2) 15.18 14.92 15.20 15.36
Resistance 1 (R1) 14.87 14.76 15.03 14.91 15.31
Pivot Point 14.50 14.50 14.57 14.52 14.50
Support 1 (S1) 14.19 14.24 14.35 14.23 13.83
Support 2 (S2) 13.82 14.08 13.84 13.78
Support 3 (S3) 13.51 13.82 13.72
Support 4 (S4) 13.55